Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05026424 · ClinicalTrials.gov registry record · NA
Glycemic Response in Adults with Diabetes
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05026424: Completed NA study, sponsored by Société des Produits Nestlé (SPN).
NCT05026424 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05026424, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This will be a randomized crossover design with oral nutrition supplement interventions.
Primary Outcome
Area under the blood glucose curve (AUC 0-240 minutes)
Interventions
- OTHER Balance oral nutritional drink - control
- OTHER Balance oral nutritional drink - test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2021-10-05 |
| Phase | NA |
What the finished NCT05026424 record still lists
NCT05026424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Balance oral nutritional drink - control is the first listed.
NCT05026424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05026424 about?
NCT05026424 is a clinical study titled "Glycemic Response in Adults with Diabetes". This will be a randomized crossover design with oral nutrition supplement interventions.
What is the current status of trial NCT05026424?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-08-02. Estimated completion is 2021-10-05.
What interventions are being tested in trial NCT05026424?
The interventions under investigation include: Balance oral nutritional drink - control (OTHER), Balance oral nutritional drink - test (OTHER).
Who is sponsoring clinical trial NCT05026424?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05026424's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI